By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Interleukin Genetics announced after the close of the market Thursday that revenues for the third quarter rose 41 percent year over year.

Total revenues increased to $765,416 for the three months ended Sept. 30, from $544,744 a year ago, as genetic testing service revenue rose 38 percent to $731,194 from $531,151. Other revenues came in at $34,222, up 152 percent from $13,593 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.